You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Earmarks are back, and one state’s health care industry is cashing in
The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
The FDA commissioner has been busy with public appearances in recent days. Here’s what stood out to us from his remarks.